Table 4:

Multivariate analysis of overall survival

	Hazard ratio	95% confidence limits	p-value
BMI <25 vs ≥30 *	0.6	0.4-0.9	0.03
BMI 25-30 vs ≥30	0.7	0.5-1.1	0.1
Age ≥60 vs <60	1.7	1.2-2.4	0.0005
KPS 80 vs 90-100	1	0.7-1.3	0.9
Favorable vs adverse cytogenetics	0.4	0.2-0.7	0.008
Intermediate vs adverse cytogenetics	0.5	0.3-0.6	<0.0001
HCT comorbidity index ≥3 vs 0-2	1.2	0.9-1.7	0.09
Low intensity vs intensive chemotherapy	2.3	1.6-3.4	<0.0001
No chemotherapy vs intensive chemotherapy	9.7	5.3-17.5	<0.0001

^*One patient had BMI <18.5. BMI- Body mass index; HCT- Hematopoietic cell transplant; Karnofsky performance status